Optical imaging firm submits application

Article

Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser

Imaging Diagnostic Systems has submitted the last of five modules to the FDA as part of an effort to win approval to market an optical imaging system that visualizes the blood supply to breast tumors. The system, called Computed Tomography Laser Mammography (CTLM), is designed as an adjunct to x-ray mammography for women who have dense breasts and equivocal mammograms, adding information to guide biopsy recommendations. Clinical studies of the technology began six years ago (SCAN 2/19/97).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.